[{"AccountsPayableCurrent_0_Q2_USD":9847000.0,"NetIncomeLoss_2_Q2_USD":6758000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":7661000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":6543000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":7668000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":6551000.0,"NonoperatingIncomeExpense_1_Q2_USD":-121000.0,"NonoperatingIncomeExpense_2_Q2_USD":-259000.0,"NotesIssued1_2_Q2_USD":0.0,"NumberOfOperatingSegments_2_Q2_pure":1.0,"NumberOfReportableSegments_2_Q2_pure":1.0,"OperatingIncomeLoss_1_Q2_USD":-4555000.0,"OperatingIncomeLoss_2_Q2_USD":-5535000.0,"OperatingLeaseCost_1_Q2_USD":679000.0,"OperatingLeaseCost_2_Q2_USD":1154000.0,"OperatingLeaseLiability_0_Q2_USD":17697000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2223000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":15474000.0,"OperatingLeasePayments_1_Q2_USD":944000.0,"OperatingLeasePayments_2_Q2_USD":1500000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":17400000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.034,"NetIncomeLoss_1_Q2_USD":7876000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":3000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-5902000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":385000.0,"LeaseCost_1_Q2_USD":1286000.0,"LeaseCost_2_Q2_USD":2099000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":20441000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":2960000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2256000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2415000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2611000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1416000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":2744000.0,"Liabilities_0_Q2_USD":68688000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":520969000.0,"LiabilitiesCurrent_0_Q2_USD":31275000.0,"LinesOfCreditCurrent_0_Q2_USD":3372000.0,"LongTermDebt_0_Q2_USD":7943000.0,"LongTermDebtCurrent_0_Q2_USD":2924000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":952000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":238000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":1656000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":1767000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":2350000.0,"LongTermDebtNoncurrent_0_Q2_USD":5019000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-8643000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":3000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":3000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":3000.0,"RestrictedCashCurrent_0_Q2_USD":53000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-90627000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":31204000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":48051000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":440000.0,"SellingAndMarketingExpense_1_Q2_USD":3142000.0,"SellingAndMarketingExpense_2_Q2_USD":5164000.0,"ShareBasedCompensation_2_Q2_USD":4024000.0,"ShortTermLeaseCost_1_Q2_USD":450000.0,"ShortTermLeaseCost_2_Q2_USD":661000.0,"StockholdersEquity_0_Q2_USD":452281000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_2_Q2_USD":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":364000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":608000.0,"VariableLeaseCost_1_Q2_USD":157000.0,"VariableLeaseCost_2_Q2_USD":284000.0,"WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_1_Q2_USD":0.0,"WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_2_Q2_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":40390098.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":38275603.0,"ResearchAndDevelopmentExpense_2_Q2_USD":5032000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":3045000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":12738000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":16450000.0,"OtherLiabilitiesCurrent_0_Q2_USD":130000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":56000.0,"OtherNonoperatingExpense_1_Q2_USD":0.0,"OtherNonoperatingExpense_2_Q2_USD":1000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":175000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":4407000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"PreferredStockValue_0_Q2_USD":0.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":4194000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4156000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":11800000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-380000.0,"ProceedsFromSaleOfMachineryAndEquipment_2_Q2_USD":1000.0,"ProceedsFromWarrantExercises_2_Q2_USD":0.0,"ProductWarrantyAccrual_0_Q2_USD":3414000.0,"ProductWarrantyAccrualAdditionsFromBusinessAcquisition_2_Q2_USD":3353000.0,"ProductWarrantyAccrualClassifiedCurrent_0_Q2_USD":3414000.0,"ProductWarrantyAccrualPayments_2_Q2_USD":761000.0,"ProductWarrantyAccrualWarrantiesIssued_2_Q2_USD":610000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":21559000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":0.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":11805000.0,"InventoryNet_0_Q2_USD":25866000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":9867000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":76200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":76299000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-14160000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":0.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"CommonStockSharesIssued_0_Q2_shares":40560720.0,"CommonStockSharesOutstanding_0_Q2_shares":40560720.0,"CommonStockValue_0_Q2_USD":41000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":7879000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":6761000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":944000.0,"CostsAndExpenses_1_Q2_USD":35759000.0,"CostsAndExpenses_2_Q2_USD":53586000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":8084000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_2_Q2_USD":0.0,"DeferredCompensationLiabilityCurrent_0_Q2_USD":4396000.0,"DeferredFinanceCostsNet_0_Q2_USD":141000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-12552000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":76246000.0,"CashAcquiredFromAcquisition_2_Q2_USD":43000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":0.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":5524000.0,"AccountsReceivableNetCurrent_0_Q2_USD":21093000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":49000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":978000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":5109000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":3000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":542864000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2520000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":4024000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2520000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":4024000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":10973000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":107000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":2815000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":0.0,"Assets_0_Q2_USD":520969000.0,"AssetsCurrent_0_Q2_USD":127414000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q2_USD":272000.0,"BusinessCombinationAcquisitionRelatedCosts_2_Q2_USD":1271000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":1718000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":1226000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":2854000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":1882000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":38072712.0,"DepositsAssetsNoncurrent_0_Q2_USD":452000.0,"Depreciation_2_Q2_USD":1400000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":8951000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":9329000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":9396000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":81274000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":7146000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":11974000.0,"Goodwill_0_Q2_USD":195664000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-4676000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-5794000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-12552000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-12552000.0,"IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2_Q2_USD":-8500000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2790000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":8494000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-3882000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-1283000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":0.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":155640000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":148714000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-121000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-137000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":4713000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":9426000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":6926000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.061,"DepreciationDepletionAndAmortization_2_Q2_USD":1895000.0,"DerivativeLiabilitiesCurrent_0_Q2_USD":0.0,"EarningsPerShareBasic_1_Q2_USD":0.2,"EarningsPerShareBasic_2_Q2_USD":0.18,"EarningsPerShareDiluted_1_Q2_USD":0.19,"EarningsPerShareDiluted_2_Q2_USD":0.17,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":2.17,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":3000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":0.0,"Depreciation_1_Q2_USD":819000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":121000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":144000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":367000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":568000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":171000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":37000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":101000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":171000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":86000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":57000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":511000.0,"FinanceLeaseLiability_0_Q2_USD":511000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":35668124.0,"Ticker":"BLFS","CIK":"834365","name":"BIOLIFE SOLUTIONS INC","OfficialName":"BioLife Solutions Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"708458227.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20210816"}]